UPDATE: UBS Upgrades AbbVie
July 28, 2014 at 11:20 AM EDT
UBS analyst Marc Goodman upgraded AbbVie (NYSE: ABBV) from Neutral to Buy and raised the price target to $67 based on several key ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|